Mealey's (October 18, 2019, 9:53 AM EDT) -- WASHINGTON, D.C. — Review of a federal appellate panel’s ruling addressing the correctness of a “no ultimate harm” (NUH) jury instruction in the conviction of former pharmaceutical company CEO and hedge fund manager Martin Shkreli on charges that he bilked investors of millions of dollars in investments is necessary because such a ruling is an issue of first impression that should be decided by the U.S. Supreme Court, Shkreli argues in an Oct. 10 petition for writ of certiorari (Martin Shkreli v. United States of America, No. 19-495, U.S. Sup.)....